Merck KGaA Buys Bio‑Techne for €10B: A Strategic Boost for Life‑Science Innovation
Merck KGaA’s €10 billion takeover of Bio‑Techne boosts life‑science innovation, combining diagnostics with protein‑analysis to unlock new R&D synergies and market share.
4 minutes to read








